Duarte-Filho, Oscar Barbosa
Miyadahira, Eduardo Hideki
Matsumoto, Larissa
Yamakami, Lucas Yugo Shiguehara
Tomioka, Renato Bussadori
Podgaec, Sergio
Article History
Received: 18 October 2023
Accepted: 8 December 2023
First Online: 2 January 2024
Declarations
:
: The study was approved by the local ethics committee (Hospital Israelita Albert Einstein, CAAE19795519.4.0000.0071), is registered in the Brazilian Registry of Clinical Trials (UTN code: 1111-1247-3260) and was conducted in accordance with the norms and guidelines of the National Research Ethics Commission of the National Health Council of Brazil. All participants signed a written informed consent form before being included in the study.
: This is an investigator-initiated study conducted with funding from Ferring Pharmaceuticals. The funder had no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.Dr. Oscar Barbosa Duarte-Filho is a speaker at Ferring Pharmaceuticals in Brazil.